Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain.

This publication has 19 references indexed in Scilit:

• Human cancer-associated gangliosides defined by a monoclonal antibody (IB9) directed to sialosylα2→6galactosyl residue: A preliminary note
  Biochemical and Biophysical Research Communications, 1983
• Marker of peripheral blood granulocytes and monocytes of man recognized by two monoclonal antibodies VEP8 and VEP9 involves the trisaccharide 3‐fucosyl‐N‐acetyllactosamine
  European Journal of Immunology, 1982
• Murine embryonic antigen (SSEA-1) is expressed on human cells and structurally related human blood group antigen I is expressed on mouse embryos
  Developmental Biology, 1982
• Monoclonal antibodies directed against the sugar sequence of lacto-N-fucopentaose III are obtained from mice immunized with human tumors
  Archives of Biochemistry and Biophysics, 1982
• Stage-specific embryonic antigen involves αl→ 3 fucosylated type 2 blood group chains
  Nature, 1981
• The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: A preliminary note
  Biochemical and Biophysical Research Communications, 1981
• Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)
  International Journal of Cancer, 1980
• Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2).
  The Journal of Experimental Medicine, 1979
• Continuous cultures of fused cells secreting antibody of predefined specificity
  Nature, 1975
• Preparation and Properties of Antisera against the Lipid‐A component of Bacterial Lipopolysaccharides
  European Journal of Biochemistry, 1971